| |
| |
|
| Insider
Information: |
Spencer David M. |
| Relationship: |
Chief Technology Officer |
| City: |
Houston |
| State: |
TX |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
92,470 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$6,912 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
92,470 |
|
|
| Total
Value |
$6,912 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Bellicum Pharmaceuticals, Inc |
BLCM |
Chief Technology Officer |
2019-01-03 |
92,470 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BLCM |
Bellicum Pharmaceuticals,... |
Chief Technology Officer |
• – – |
2019-01-03 |
4 |
D |
$3.20 |
$1,885 |
D/D |
(589) |
92,470 |
0 |
- |
|
| BLCM |
Bellicum Pharmaceuticals,... |
Chief Technology Officer |
• – – |
2019-01-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,562 |
93,059 |
0 |
- |
|
| BLCM |
Bellicum Pharmaceuticals,... |
Chief Technology Officer |
• – – |
2019-01-02 |
4 |
D |
$3.33 |
$3,137 |
D/D |
(942) |
91,497 |
0 |
- |
|
| BLCM |
Bellicum Pharmaceuticals,... |
Chief Technology Officer |
• – – |
2019-01-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,500 |
92,439 |
0 |
- |
|
| BLCM |
Bellicum Pharmaceuticals,... |
Chief Technology Officer |
• – – |
2018-09-04 |
4 |
AS |
$7.04 |
$70,413 |
D/D |
(10,000) |
89,939 |
0 |
- |
|
| BLCM |
Bellicum Pharmaceuticals,... |
Chief Technology Officer |
• – – |
2018-07-18 |
4 |
AS |
$7.63 |
$305,132 |
D/D |
(40,000) |
99,939 |
0 |
- |
|
| BLCM |
Bellicum Pharmaceuticals,... |
Chief Scientific Officer |
• – – |
2018-01-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,563 |
140,528 |
0 |
- |
|
| BLCM |
Bellicum Pharmaceuticals,... |
Chief Scientific Officer |
• – – |
2018-01-03 |
4 |
D |
$9.79 |
$5,766 |
D/D |
(589) |
139,939 |
0 |
- |
|
| BLCM |
Bellicum Pharmaceuticals,... |
Chief Scientific Officer |
• – – |
2017-07-10 |
4 |
AS |
$11.54 |
$115,400 |
D/D |
(10,000) |
138,965 |
0 |
- |
|
| BLCM |
Bellicum Pharmaceuticals,... |
Chief Scientific Officer |
• – – |
2016-12-05 |
4 |
AS |
$20.00 |
$100,000 |
D/D |
(5,000) |
146,082 |
0 |
- |
|
| BLCM |
Bellicum Pharmaceuticals,... |
Chief Scientific Officer |
• – – |
2016-12-01 |
4 |
AS |
$17.17 |
$87,624 |
D/D |
(5,000) |
151,082 |
0 |
- |
|
| BLCM |
Bellicum Pharmaceuticals,... |
Chief Scientific Officer |
• – – |
2016-09-23 |
4 |
AS |
$20.19 |
$125,172 |
D/D |
(6,200) |
156,082 |
0 |
- |
|
| BLCM |
Bellicum Pharmaceuticals,... |
Chief Scientific Officer |
• – – |
2016-09-22 |
4 |
AS |
$19.68 |
$196,832 |
D/D |
(10,000) |
162,282 |
0 |
- |
|
| BLCM |
Bellicum Pharmaceuticals,... |
Chief Scientific Officer |
• – – |
2016-09-21 |
4 |
AS |
$20.04 |
$6,012 |
D/D |
(300) |
172,282 |
0 |
- |
|
| BLCM |
Bellicum Pharmaceuticals,... |
Chief Scientific Officer |
• – – |
2016-09-20 |
4 |
AS |
$20.00 |
$2,000 |
D/D |
(100) |
172,582 |
0 |
- |
|
| BLCM |
Bellicum Pharmaceuticals,... |
Chief Scientific Officer |
• – – |
2016-09-19 |
4 |
AS |
$20.02 |
$14,013 |
D/D |
(700) |
172,682 |
0 |
- |
|
| BLCM |
Bellicum Pharmaceuticals,... |
Chief Scientific Officer |
• – – |
2016-09-16 |
4 |
AS |
$20.01 |
$34,015 |
D/D |
(1,700) |
173,382 |
0 |
- |
|
| BLCM |
Bellicum Pharmaceuticals,... |
Chief Scientific Officer |
• – – |
2016-08-15 |
4 |
AS |
$20.00 |
$20,000 |
D/D |
(1,000) |
175,082 |
0 |
- |
|
| BLCM |
Bellicum Pharmaceuticals,... |
Chief Scientific Officer |
• – – |
2016-07-27 |
4 |
AS |
$15.00 |
$150,000 |
D/D |
(10,000) |
176,082 |
0 |
- |
|
| BLCM |
Bellicum Pharmaceuticals,... |
Chief Scientific Officer |
• – – |
2015-12-14 |
4 |
OE |
$2.55 |
$12,750 |
D/D |
5,000 |
184,559 |
0 |
- |
|
| BLCM |
Bellicum Pharmaceuticals,... |
Chief Scientific Officer |
• – – |
2015-12-01 |
4 |
AS |
$22.95 |
$114,739 |
D/D |
(5,000) |
178,600 |
0 |
- |
|
| BLCM |
Bellicum Pharmaceuticals,... |
Chief Scientific Officer |
• – – |
2015-09-21 |
4 |
OE |
$2.55 |
$12,750 |
D/D |
5,000 |
183,600 |
0 |
- |
|
| BLCM |
Bellicum Pharmaceuticals,... |
Chief Scientific Officer |
• – – |
2015-09-11 |
4 |
AS |
$19.00 |
$95,000 |
D/D |
(5,000) |
178,600 |
0 |
- |
|
| BLCM |
Bellicum Pharmaceuticals,... |
Chief Scientific Officer |
• – – |
2015-07-02 |
4 |
OE |
$2.55 |
$51,000 |
D/D |
20,000 |
183,600 |
0 |
- |
|
| BLCM |
Bellicum Pharmaceuticals,... |
Chief Scientific Officer |
• – – |
2015-06-16 |
4/A |
AS |
$22.82 |
$459,173 |
D/D |
(20,000) |
163,600 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
